Intranasal Steroid Therapy for Allergic Rhinitis

Area of Science:

• Pediatric Allergy and Immunology
• Otolaryngology
• Pharmacology

Background:

• Allergic rhinitis (AR) is a prevalent childhood condition impacting quality of life.
• Effective prevention and symptom management are key treatment goals for AR.
• Pharmacotherapy is frequently required to alleviate AR symptoms and associated morbidity.

Purpose of the Study:

• To review the efficacy and safety of intranasal steroids (INS) for treating pediatric allergic rhinitis.
• To compare the effectiveness of INS with other AR pharmacotherapies.
• To identify potential adverse effects associated with INS use in children.

Main Methods:

• Literature review of studies on intranasal steroids for allergic rhinitis treatment.
• Comparative analysis of INS efficacy against antihistamines and leukotriene modifiers.
• Assessment of safety profiles and adverse events reported for INS.

Main Results:

• Intranasal steroids (INS) demonstrate higher efficacy in treating AR compared to antihistamines and leukotriene modifiers.
• Multiple INS formulations exhibit similar efficacy and safety.
• Local irritation is the most common adverse effect; systemic effects are rare due to low absorption.

Conclusions:

• Intranasal steroids are a highly effective treatment option for pediatric allergic rhinitis.
• While generally safe, potential risks such as hypothalamic-pituitary-axis suppression exist with prolonged INS use, particularly when combined with systemic steroids.
• Monitoring for adverse effects is recommended during long-term INS therapy.